Findings in Fabry Disease Reported from Charles University and General University Hospital Prague (Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, ...)

Prensa/medios de comunicación: Research

Períodonov. 8 2023

Cobertura de los medios

1

Cobertura de los medios

  • NombreFindings in Fabry Disease Reported from Charles University and General University Hospital Prague (Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, ...)
    Nombre/canal del medio de comunicaciónClinical Trials Daily
    País/TerritorioUnited States
    Fecha11/8/23
    PersonasMichael L. West